BioSpace News Archive

PTC Therapeutics announced interim data from Part 1 of its open-label clinical trials, FIREFISH and SUNFISH, of risdiplam for Type 1, 2 and 3 spinal muscular atrophy in collaboration with Genentech.

Epigenomics AG today announced that the U.S. Congress urges the Centers of Medicare & Medicaid Services (CMS) to consider coverage of colorectal cancer screening blood tests as part of the approved 2019 Health and Human Services (HHS) Appropriations Bill.

High Performance Nutrition, Inc. has announced an exclusive collaboration with Ambrosia Nutraceuticals, LLC. in bringing the next evolution in plant-based protein.

Arix co-leads a $58 million Series A investment in new Group Business, VelosBio Inc., bringing core portfolio1 to 15 companies

Data Supports Akari’s Ongoing Clinical Expansion into a Range of Orphan Autoinflammatory Diseases That Are Either Mediated by Complement C5 or Have Synchronous C5 and Leukotriene B4 (LTB4) Activity

The American College of Foot and Ankle Surgeons (ACFAS) partnered with The Joint Commission, the Centers for Diseases Control and other healthcare specialty organizations on a three-year initiative, Adaptation and Dissemination for Outpatient Infection Prevention (ADOPT) Guidance, to help ensure patients are provided care in environments that minimizes or eliminates the risk of healthcare-associated infections.

Immunicum AB today announced that Nasdaq Stockholm decided to halt trading in the Company’s share as a result of share price movements.

Ergomed plc today announces two Board changes with immediate effect.

HERA-CD27L Enhances T Cell Activation and Induces Anti-Tumor Immunity

KOL event to be held ahead of expected data release with elafibranor in PBC by end of 2018 (Phase 2) and in NASH end of 2019 (Phase 3)